The effect of TGF-β1 gene silencing by shRNA on the proliferation of human mucoepidermoid salivary gland carcinoma Ms cells

Chinese Journal of Clinical Oncology

Volumn 34, Issue 1, 2007, Pages 18-21

  Wang, Jing ^a   Wu, Junzheng ^a   Wei, Hongyu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Salivary gland mucoepidermoid carcinoma; shRNA; Transforming growth factor 1

Indexed keywords

EID: 77951542933     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Boado RJ. RNA interference and nonviral targeted gene therapy of experimental brain cancer [J]. NeuRorx, 2005, 2(1):139-150
2. Chen LM, Le HY, Qin RY, et al. Reversal of the phenotype by K-ras (val12) silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1 [J]. World J Gastroenterol, 2005, 11(6):831-838
3. Pasche B. Role of transforming growth factor beta in cancer [J]. J Cell Physiol, 2001, 186(2):153-168 (Pubitemid 32041875)
4. Akhurst RJ, Derynck R. TGF-β1 signaling in cancer: a double-edged sward [J]. Trends Cell Biol, 2001, 11(11):44-51 (Pubitemid 33001443)
5. Ye SC, Foster JM, Li W, et al. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells [J]. Cancer Res, 1999, 59(18):4725-4731 (Pubitemid 29428983)
6. Gupta S, Schoer RA, Egan JE, et al. Inducible, reversible, and stable RNA interference in mammalian cells [J]. Proc Natl Acad Sci USA, 2004, 101(7):1927-1932 (Pubitemid 38228992)
7. Saulnier A, Pelletier I, Labadie K, et al. Complete cure of persistent virus infections by antiviral siRNAs [J]. Mol Ther, 2006, 13 (1):142-150 (Pubitemid 41763492)
8. Friese MA, Wischhusen J, Wick W, et al. RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo [J]. Cancer Res, 2004, 64(20):7596-7603 (Pubitemid 39372105)